(Q43638540)

English

Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).

scientific article published in April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

1

object named as

R N Jones

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Michael A. Pfaller

2

object named as

M A Pfaller

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

SENTRY Antimicrobial Surveillance Program Participants Group (USA)

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

237-243

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibacterial properties of AM-1155, a new 8-methoxy quinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration result.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900229-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(01)00229-2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43638540&oldid=2102035375"